Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,447 total articles
Terra Innovatum Global N.V. filed its Q1 2026 Form 10-Q, regaining current SEC reporting status. The company reported continued investments and progress in licensing, procurement, manufacturing readiness, and commercialization planning for its SOLO™ micro modular nuclear reactor, targeting first-of-a-kind deployment within three years. Financial re…
SLR Investment Corp., a specialty finance company focused on lending to U.S. middle market companies, announced it will release its financial results for Q2 ending June 30, 2026, on August 4, 2026, followed by an earnings call on August 5. The company invests primarily in senior secured loans and asset-backed loans to leveraged middle market firms.
NewAmsterdam Pharma announced it will present clinical data at the Alzheimer's Association International Conference 2026, highlighting obicetrapib, its oral CETP inhibitor initially developed for cardiovascular disease, as a promising low-dose therapy for early Alzheimer's disease prevention. The presentations include biomarker analyses from the BR…
BridgeBio Pharma, a US-based biopharmaceutical company (Nasdaq: BBIO), announced a $1 billion preferred equity investment led by Sixth Street and HealthCare Royalty (a business of KKR). The financing, which includes a convertible preferred stock with an initial 7% dividend and a conversion price at a significant premium to market price, aims to bol…
NorthStrive Biosciences, a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB), announced positive Phase III results from their AI-driven drug discovery collaboration with Yuva Biosciences. Four AI-selected small-molecule compounds demonstrated significant induction of the mitochondrial protein ANT1 in human skeletal muscle cells, supporting further co…
FortuneX Acquisition Corporation announced that its IPO units, each consisting of one ordinary share and one redeemable warrant, can now be separated and traded independently on the Nasdaq starting July 1, 2026. Unseparated units will continue trading under FXACU, while separated shares and warrants will trade under FXAC and FXACW respectively.
FTI Consulting announced a significant increase and extension of its senior unsecured revolving credit facility from $900 million to $1.5 billion, with maturity extended to June 2031. This follows the company's recent upgrade to investment grade by S&P Global and includes improved pricing and less restrictive covenants, providing greater financial …
Streamex Corp. announced that EisnerAmper LLP completed the first independent examination confirming that the GLDY tokens are fully backed by gold reserves meeting or exceeding 100%, marking the start of ongoing monthly attestations. This third-party verification supports transparency and institutional trust in GLDY, Streamex's gold-backed, yield-b…
New Era Energy & Digital, a Nasdaq-listed company focused on developing large-scale data centers in energy-rich U.S. markets, announced a leadership transition effective July 1, 2026. Charlie Nelson has been promoted to Chairman and CEO, while Ted Warner becomes President and CFO, and José Rodriguez joins as COO bringing extensive data center and e…
Kustom Entertainment, Inc. announced record-breaking attendance of over 42,000 fans at its 30th anniversary Country Stampede festival in Kansas, surpassing projections by 10,000. Fueled by strong demand and a newly announced multi-season partnership with Gilley's Park City, the company plans to expand event capacity significantly in 2027. Multiple …
Marex Group Limited has completed its redomiciliation from England and Wales to Bermuda, effective July 1, 2026. This move follows shareholder approval and regulatory and court sanctioning. The redomiciliation aims to rationalize the company's corporate and regulatory framework, deliver cost savings, and align its governance under Bermuda's US-styl…
Hotel101 Global Holdings Corp. (NASDAQ: HBNB) announced definitive binding agreements to jointly develop a large 770-room Hotel101 in Bangkok, Thailand, in partnership with Origin Property PCL. Positioned in a prime location near Don Mueang International Airport and a BTS Skytrain station, the hotel aims to be one of Bangkok's largest by room count…
GlobalFoundries announced it will host a conference call on August 5, 2026, to review its second quarter 2026 financial results. The company is a leading semiconductor manufacturer serving multiple high-growth markets with global operations.
Biotech firm Ocugen, Inc. announces participation in multiple July 2026 conferences to showcase its modifier gene therapy platform targeting blindness diseases. Presentations will cover updates on ongoing clinical trials and research advances in retinal disease therapies, highlighting the company’s gene-agnostic approach aimed at treating complex i…
Ocular Therapeutix, a biopharmaceutical company focused on retinal diseases, announced its participation in several prominent scientific and investor conferences in July 2026. Key presentations will include Phase 3 clinical trial results for its investigational intravitreal axitinib hydrogel (AXPAXLI/OTX-TKI) targeting neovascular age-related macul…
Gaming and Leisure Properties, Inc. (GLPI), a real estate investment trust specializing in gaming property leasing, announced it will release its second quarter 2026 financial results on July 30, 2026, following the market close. A conference call with senior management will be held on July 31, 2026, to discuss the quarterly performance and recent …
iBio, Inc. announced that their investigational antibody therapy IBIO-610 achieved up to 98% inhibition of active Activin E for eight weeks in an obese non-human primate study. When combined with semaglutide, IBIO-610 enhanced fat loss while significantly reducing lean mass loss compared to semaglutide alone. These results support IBIO-610’s potent…
Gogo announced that Gulfstream Aerospace has obtained FAA Supplemental Type Certificate to install Gogo's Galileo HDX electronically steered antenna system on Gulfstream G650 and G650ER aircraft. This technology offers high-speed, low-latency inflight connectivity powered by Eutelsat's OneWeb LEO satellite network, enhancing communications for busi…
X4 Pharmaceuticals announced the appointment of Kelly Gold, an experienced CFO with a strong background in biotech finance and strategic planning, to its Board of Directors. Gold brings expertise from her roles at CAMP4 Therapeutics and Biogen, and will support the company's progression of its rare hematology therapy, mavorixafor, including ongoing…
FactSet announced its strong third quarter fiscal 2026 results showing 6.4% GAAP revenue growth and 7.1% organic Annual Subscription Value (ASV) growth year over year. The company highlighted expanding AI product adoption among top clients, key new AI partnerships, and continued commercial excellence with extended contract renewals. FactSet also ap…
INmune Bio has progressed its CORDStrom MSC platform patent application into the U.S. national phase following a favorable international patent opinion. This move strengthens the company's intellectual property portfolio, potentially securing market exclusivity through 2045 for its lead product Ebstrocel and future engineered cell therapies. The co…
Harrow, Inc. has announced the commercial launch of BYOOVIZ® (ranibizumab-nuna), the first FDA-designated interchangeable biosimilar to LUCENTIS® for treating retinal diseases in the U.S. This launch, under an exclusive commercialization agreement with Samsung Bioepis, expands Harrow's retina portfolio including OPUVIZ®, IHEEZO®, and TRIESENCE®, po…
Seer, Inc. announced the successful defense of its European patent EP4056263 related to its particle-based proteomics technology and the initiation of an investigation by the U.S. International Trade Commission into alleged patent infringement by Nanomics Biotechnology Co., Ltd. These developments strengthen Seer's intellectual property portfolio a…
NN, Inc. disclosed a private placement agreement to raise $75 million through issuance of approximately 24.5 million common shares at $3.06 per share. Proceeds are planned to support working capital and general corporate purposes, including actions to optimize the company’s balance sheet. The transaction is expected to close on July 2, 2026, subjec…
HUB Cyber Security has acquired senior subordinated convertible notes and purchase rights of Evofem Biosciences through an equity swap at no cash cost, supporting its broader transformation strategy to strengthen finances, streamline operations, and enhance governance. Alongside the acquisition, HUB has implemented significant cost reductions and i…
